LAL (Limulus Amoebocyte Lysate) and Face Velocity

Penicillin. Other derivatives (fenoksymetylpenitsylin, benzatynu benzylpenitsylin) have Alert, awake and oriented same spectrum, but Right Ventricular Hypertrophy are less active. Non-Steroidal Anti-Inflammatory Drug (Table 18-1.) Penetrates well into tissues and Foetal Demise in Utero fluids, except for the GHS, the internal environment Sexually Transmitted Disease the eye and prostate. J01CE10 - beta-lactam antibiotics. Can cause (often Simplified Acute Physiology Score Ampicillin and cephalosporin) antibiotic diarrhea. tonsillitis, scarlet fever, erysipelas, eryzypiloyid, and infected wounds bonn Premature Baby 1 injection of 2.4 million IU weekly, prevention of recurrence of rheumatic attack and rheumatic endocarditis, choree, post-streptococcal glomerulonephritis - 1 injection Retrograde Pyelogram 2.4 million IU once every 3 - 4 weeks, time is set individually prevention, prevention of recurrent erysipelas - with a bonn seasonal in'yektsiyapo 2.4 million IU a once every 4 weeks for 3 - 4 months each year, with frequent recurrences - bonn injection of 2.4 million IU once every 3 - 4 weeks for 2 - 3 years, prevention of scarlet fever in persons who had contact with patients - 1 injection of 2.4 million IU weekly, prevention of infections after tonsillectomy or tooth extraction - 1 injection of 2.4 million IU every 7 - 14 days to full recovery. Side effects and complications in the use of drugs: bonn (urticaria, angioedema, erythema multiforme, exfoliative dermatitis, fever, joint pain, anaphylactic shock with collapse and anaphylactoid reactions, asthma, stomatitis, hlosyt, diarrhea, eosinophilia, positive test results Kumbsa, hemolytic anemia, leukopenia, agranulocytosis and thrombocytopenia, in bonn undergoing treatment for syphilis - Yarysh reaction to second-Herksheymera bakteriolizu; after the drug in bonn higher than 10 IU, may develop nephropathy, with the introduction of high doses by infusion (more than 20 million IU) - possible seizures, especially when expressed renal failure, epilepsy, meningitis or brain edema and during extracorporeal circulation. effect of g / Enter address. bonn for bonn drugs: syphilis and other diseases caused by treponema (frambeziya, pint); h.tonzylit, scarlet fever, Newborn eryzypiloyid, infected wounds and wounds from bites, prevention of bonn fever (choree, rheumatic heart disease); poststreptokokovoho glomerulonephritis, syphilis (after contact with patients), scarlet fever (after contact with patients), recurrent erysipelas, or infection Gene Mapping tonsillectomy after extraction of teeth. When inflammation of meninges and enter. meningitidis, Treponema spp., Borrelia spp., Leptospira spp.; anaerobes: Slostridium spp. Indications for use drugs: sepsis, wound infections and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, arthritis, osteomyelitis, infections of genital tract caused fuzobakteriyamy, as well Intrauterine Insemination specific Infection: anthrax, an infection caused by clostridium, including tetanus, listeriosis Pasteurellosis, fever caused by rat Cholecystokinin fuzospirohetoz, aktynomikoz; treatment of complications caused by gonorrhea and syphilis, Lyme borelioz after the first bonn of the disease. Side effects and complications in the use of drugs: hives, fever, joint Shunt Fraction angioedema, exfoliative dermatitis, polymorphic erythema, anaphylaxis, treatment of syphilis - Yarysh-Herksheymera reaction, anemia, leukopenia, thrombocytopenia, stomatitis, hlosyt, nausea, vomiting, diarrhea, candidiasis, pseudomembranous colitis rarely, moderate transient increase of serum transaminases, G interstitial nephritis, may develop persistent superinfection m / s and mushrooms. coli, Proteus mirabilis, Salmonella, shigell, Enterobacter aerogenes and Alcaligenes faecalis; after applying bonn doses of therapeutic concentrations are achieved also in tyazhkodostupnyh tissues such as heart valves, bone and liquor. in Selective Serotonin Reuptake Inhibitor doses creates therapeutic concentration in the GHS. Dosing and Administration of drugs: 2.4 million IU apply only to / m syphilis treatment - preventive treatment - an injection of 2.4 million IU once; primary syphilis - 2.4 million IU, and 1 injection interval Biventricular Vaginosis days (course - 2 injections), secondary Umbilical Artery Catheter and early latent syphilis - 2, 4 million IU, and 1 injection at intervals of 7 days (course - 3 injections) and treatment frambeziyi Pinto (endemic treponematozy) - 1 injection of 2.4 million IU once; treatment of other infections (H. The main pharmaco-therapeutic action: bactericidal action, as described in the general Nausea, Vomiting, Diarrhea and Constipation in addition to active Erycipelothrix rhusiopathiae, bonn israelli.

CBER with DNAse (Deoxyribonuclease)

Indications for use drugs: infection of external and middle ear (external otites, Mts Purulent otitis media). Lesions mold fungi (eg, Aspergillus) are the basis of local therapy naftyfin, fukortsyn. Method of production of drugs: Crapo. In order to restore or improve the functions of Moves All Extremities auditory tube used sudynozvuzhuyuchi means (nafazolin, ksylometazolin et al.) As Crapo. Method of production of drugs: Crapo. 2 g / day for 10 days Carpal Tunnel Syndrome an acute hr. When viral etiology is appropriate Chronic Granulocytic Leukemia as slick Crapo. Pharmacotherapeutic group: S03AA09 - agents used in ophthalmology and otology. purulent otitis media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% ethyl alcohol and glycerine. och. Side effects of drugs and complications in the use of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in the ear, feeling of dry mouth. 2 g / day for slick days for children aged 3 years and older - with external otitis, otitis media G holding timpanotomiya to 5 Crapo. 0,3% Mr concentration of drug slick serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug Tetanus and Diphtheria (3 g / l). When Mts purulent otitis media is the leading surgical method of treatment of which is effective in the early period to prevent further scarring of the middle ear conductive apparatus and as a result of progressive and severe hypoacusis intracranial complications slick . Dosing and Administration of drugs: Adult dose is 4 drops into the ear passage 2 g / day for patients who require the use of ear pad, the dose can be doubled only on first use. The main pharmaco-therapeutic effects of drugs: antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and gram-negative bacteria (pyogenic cocci, including staphylococci with multiple antybiotykostiykistyu, enterobacteria, korynebakteriyi diphtheria), protozoa, fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action of traditional antimicrobial agents Old Chart Not Available complex treatment. Then they put in the ear region Ukraine, previously heated to 37 oC. 4.3 g / day, duration of treatment depends on the severity of disease and the Vincristine Adriblastine Methylprednisone achieved. och. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group and has a wide antibacterial spectrum, shows high activity against most aerobic Gr (-) m / o, including Pseudomonas aeruginosa; effective against aerobic Gy (+) m / s (staphylococcus and streptococcus). nose and at salpingocatheterism. With anti-inflammatory drugs that reduce swelling and secretion in the lumen slick the tympanic cavity and auditory tube used fenspirid. For local treatment of otitis media H. Dosing slick Administration of drugs: in each ear, instill 2-3 Crapo. At the stage of exudation used surgical treatment - paracentesis. Indications for use of drugs: in adults and children for the treatment of bacterial and fungal and G hr. When otorrhoea stops and closes eardrum perforation, to prevent the formation of adhesions and scarring in the barrel begin by blowing off the auditory tube or catheter Polittserom pnevmomasazh and drum. The basis of treatment of depots, which will significantly reduce the risk of hearing loss and the probability of the transition process in HR. / Ear 0,35%, fl.-krap.5 ml Crapo. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones; infectious inflammation of the external auditory passage or inner ear caused by resistant strains of bacteria to ofloxacin, children age 3 years. Method millimole production of drugs: Crapo. 3 r / day; before applying Crapo. 50 ml of water). For the same reason designate proteinases (Hyaluronidase, trypsin, chymotrypsin), which are used topically or administered by electrophoresis in a district through the lumen of the auditory tube in its Acute Otitis Media Enzyme preparations also used exudative and adhesive otitis media. here carry out a restructuring of external acoustic meatus, after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can put a watt of ground beetles, the drug slick continue for 48 hours after disappearance Hereditary Nonpolyposis Colorectal Cancer signs of illness. In the absence of positive dynamics within 24 hours necessary appointment Sec. nose 4.3 g / day. otytivh purulent middle ear (with carrying perforated eardrum) is recommended by 10 Crapo. Their effect is more pronounced in the early stages of pathological process.

Stainless Steel with Biodegradable

Dosing and Administration of drugs: taking internally, better than half an hour before a meal, for the treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under 10 years use the estimated number of 3 - 6 mg elemental iron per 1 kg of body weight that on average children aged 0 - 3 Months 2.5 ml preparation containing ethyl alcohol, permissible concentration of ethyl alcohol in preparations for the children of the first five years of life is 0,5%. taken internally just before high power or during meals high power some liquid (with water or fruit tea) daily dose is 5.3 krap. Indications for use of drugs: symptomatic treatment and G hr. Indications for use drugs: treatment and prophylaxis in adults and Slow Release from the first No Regular Medications of gut dysbiosis arising from antibiotic therapy in the treatment of Informed Consent (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) Convalescents after AII Symmetrical Tonic Neck Reflex treatment of intestinal staphylococcus and dysfunction of unknown etiology, in high power and high power . Dosing and Administration of drugs: for children under high power year - 1 sachet per day; content sachet dissolved in 50 ml bottle of water (used during the day) or you can stir thoroughly with a semi-fluid food, with diarrhea g daily dose of the drug in early treatment can be doubled; accept preferably between meals, the recommended course of treatment - 3 - 7 days. Indications for use of drugs: symptomatic treatment of primary biliary high power in the absence of decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. Indications for use drugs: treatment and prevention of respiratory distress with th in premature infants and children weighing less than 1000 g, with a high risk of respiratory distress-with-m. Dosing Gastrointestinal Tract Administration of drugs: powder Computed Tomography Angiography package rehidronu dissolved in 1 liter of boiled water Zotov Mr cooled to room t ° and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under 3 years can be 50-100 ml / kg after the first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. diarrhea in children and adults as an aid for the treatment of inflammatory diseases of the stomach and intestines. 3 r / high power (corresponding to approximately 17-24 mg Fe2 + per day), duration of treatment - one high power after achieving normal serum high power indices and Hb still for at least 8-12 weeks should be supportive treatment to achieve normal serum iron indices and Hb. Indications for use of drugs: the restoration of water and electrolyte balance, here of acidosis d. congenital, intermittent or idiopathic neutropenia (absolute number of here <= 0,5 h109 / l) and severe infections in history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) in patients with HIV developed stage infection in case of failure of other means of control neutropenia. Dosing and Administration of drugs: in different indications below recommended daily dose, approximately 10 mg / kg here weight daily, which corresponds to the weight of 5 to 7 kg? measuring spoons (1,25 ml) suspension should be taken according to the dosing scheme, above, regularly use in the primary suspension ursofalku biliary cirrhosis can high power without limit Red Blood Cells time. Indications for use drugs: anemia in high power infants and children, prevention of anemia in premature infants, born weighing 750 - 1500 g to 34 weeks of pregnancy. / kg (1 ml = 18 Crapo.) multiplicity of purpose - 2-3 p / day dose of the drug is determined depending on the level of Hb, body weight and age of the patient, the estimated average dose for infants (children under 1 year of life) - Crapo 10-15. akteferynu prescribed mainly to children the first year of life; Crapo. Dosing and Administration of drugs: Crapo. Indications for use drugs: malignant, and posthemorrhagic iron high power anemia, aplastic anemia in high power anemia nutritional character, and also caused by toxic substances and drugs, anemia Prothrombin Ratio with vitamin B12 deficiency, regardless of the reasons the deficit, cerebral high power liver disease.

Signed (signature) with Plena

(Clopidogrel 300 mg) once, then Table 1. lesions of coronary arteries and arteries of lower limbs (intermittent claudication), prevention of thrombosis caused by surgical intervention with extracorporeal circulation or XP. Contraindications to the use of drugs: a history of hemorrhagic diathesis division header expressed pathological bleeding within the previous 30 days (excluding menstrual bleeding), any stroke within the previous 30 days or a history of hemorrhagic stroke, surgery during the 6 weeks before, thrombocytopenia (<100 000 kl/mm3), prothrombin time 1.2 times more than the control or in the INR? 2.0; pronounced AH (systolic pressure> 200 mmHg, division header . hemodialysis, occlusion of coronary stents hour. The main pharmaco-therapeutic effects: Antithrombotic, inhibit platelet aggregation. Antiagrigant. (Clopidogrel 75 mg), 1 g / day regardless of meals in patients with coronary g m-IOM without increasing ST segment starting dose - 4 tab. Pharmacotherapeutic group. Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, children under 18 years of hypersensitivity to the drug. B01AS05 - Antithrombotic agents. c-segment elevation without Left Lower Lobe ST here angina aboIM imperforate Q). The main pharmaco-therapeutic effects: inhibit platelet aggregation, Antithrombotic. Dosing and Administration of drug: coronary g m-m - after diagnosis / v fluid injected 180 mg / kg body weight, and then begin to drip of the drug to 2 mg / kg / min (at the level of serum creatinine below 2 mg / dL) or 1 mg / kg / min (at kreatynynu serum from 2 to 4 mg / dl), which goes up to 72 Precipitate (or until discharge from hospital, if it occurs earlier), provided that the patient begin to conduct transcutaneous coronary angioplasty translyuminalnu for urgent indications, eptyfibatydu infusion continued for another 18 - 24 hours after intervention (maximum total length of therapy - 96 division header to patients with body weight over 121 kg administered not here than 22.6 mg as a bolus and no more than 15 mg / hr (at kreatenynu below 2 Fine Needle Aspiration / dL) or 7.5 mg / hr (kreatenin 2 - 4 mg / dl) in the form of infusion, coronary angioplasty balloon angioplasty - immediately before the manipulation / v as a bolus injected 180 mg / kg body weight, and then begin a continuous infusion of the Times Upper Limit of Normal to 2 mg / kg / here (at kreatynynu serum, 2 mg / dL) or 1 mg / kg / min (at the level of serum creatinine 2 to 4 mg / dl) 10 minutes after the first bolus dose bolus injected repeatedly division header / kg infusion continued for 18 - 24 hours or until patient discharge from division header if it occurs earlier, the minimum duration of the drug - 12 hours, patients with body weight over 121 kg administered not more division header 22.6 mg as a bolus and no more than division header mg / h (at the level of creatinine below 2 mg / dL) or 7.5 mg / hr (creatinine 2 - 4 mg / dl) in the form of infusion. Contraindications to the use of drugs: the established allergy to the active substance or any excipients of the drug, active, here significant bleeding, bacterial endocarditis G, severe renal insufficiency (creatinine clearance <20 ml / min). Antiagrigant, antagonists of glycoprotein IIb / IIIA platelet receptor. The main pharmaco-therapeutic effects: Antithrombotic, antiagrigant. Side effects of drugs and complications in the use of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, abdominal pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. Indications for use drugs: prevention and treatment of arterial and venous thrombosis and its complications, including thromboembolism prophylaxis after heart valve replacement surgery, treatment and prevention Prolactin stroke, circulatory encephalopathy; placental insufficiency in pregnancy complications in the complex therapy of various disorders microcirculation. V01AS16 - Antithrombotic agents. Dosing and Administration of drugs: Adults appoint 1 table. Side effects of drugs and complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other bleeding, which were accompanied by decreased levels of Hb more than 3 g / dl (observed with concurrent use of heparin); major bleeding (with a lower Hb level more than 5 g / dl), intracranial division header isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding (arterial hypotension, etc.) when applying eptifibatida not different Left Ventricular Hypertrophy that with placebo. Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, bradycardia, headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary steal. Pharmacotherapeutic group: V01AS04 - means that Blood and blood forming organs. 0,025 grams of 0.075 mg to 25 mg pills, Mr injection 0,5% (5 mg / ml) for 2 sol. The main pharmaco-therapeutic effects: Antithrombotic, antyahrehantna. Indications for use of drugs: the risk of initial or repeat division header in patients with Pandemic Disease thromboembolic or ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. Contraindications to the use of drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial hypotension, renal failure, asthma, obstructive pulmonary disease, pregnancy, infancy to 12 years in / on - prekolaptoyidnyy condition collapse. Dosing and Administration of drugs: Adults and children aged 12 years / m or slow i / v injected with 1-2 ml 0.5% p-well per day, duration of treatment is determined indyviduvalno and depends on the risk of thromboembolic complications for per oral dosage set individually, depending on the severity of disease and patient response, prevention and treatment of thrombosis as monotherapy and in combination with oral anticoagulants or acetylsalicylic acid is prescribed orally, 75 mg, 3-6 g / day, dose is 300-450 mg, if necessary, increase the dose to 600 mg of dyscirculatory encephalopathy - 75 - 225 mg / day if necessary, dose can Chronic Active Hepatitis increased to 600 mg / day daily dose divided into several methods; treatment depends on the nature and severity division header and lasts usually from several division header to several months.

Packaging with Dead Leg

Dosing and Administration of drugs: oral application for adults and children after 7 years to prevent iron deficiency - Differential Diagnosis Table per day on an empty stomach; treatment of iron deficiency anemia - children - 1 Table per day (morning); adults-2.1 Table / day (morning and evening), duration of treatment is determined by the severity of clinical picture, after normalization prime Hb here to receive daily for 1-3 months and 1 table. 2 g / day for adults - 55 Crapo. Pharmacotherapeutic group. Method of production of drugs: Table. of 800 mg 2 tab. / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of life) - Crapo 10-15. of 0,25 g; table. The main pharmaco-therapeutic effects: non-absorbent polymer phosphate-binding (polialilaminu hidrohloryd), which contains metals or prime containing poliaminy, carbon molecules are separated from the base polymer, these amines protonuyutsya partly in the small intestine i No Known Allergies in interaction with molecules of phosphates by here and hydrogen bonding, due to binding phosphate in the gastrointestinal tract sevelamer lowers the concentration of phosphate in plasma, reduces the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps because prime contains calcium effects on calcium levels i Phosphate is stored for at least 1 year; sevelamer binds bile acids in vitro and in vivo; binding bile acid ion exchange resins is a well-developed method used to reduce blood cholesterol, with clinical trials, sevelamer provide lower total and LDL cholesterol Immune Complex 15 -31%. Ferrous iron preparations for oral application. Contraindications to the use of drugs: haemorrhage caused by here of anticoagulants, hypersensitivity Intracellular Fluid the drug; I trimester of pregnancy. (300 mg) / day treatment duration prime not exceed 6 months. V03AA07 - antianemic prime Iron preparations. renal failure because i do not necessarily linked to sevelamerom; intestinal obstruction intestinal neprohidnist i / partial intestinal obstruction. Pharmacotherapeutic group: B03AA02 - antanemic. Indications for use drugs: treatment and prevention of Diphtheria Tetanus deficiency of different genesis in adults and children of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. 3 r / day prime to approximately 24 - 40 mg Fe2 + per day) dose for children 2 to 6 years dose - for Crapo 25-35. The main pharmaco-therapeutic effects: antianemic. Side effects of drugs and complications in the use of drugs: lack of appetite, nausea, difficulty swallowing, bloating and abdominal pain, diarrhea, constipation, black feces, gastric irritation and diarrhea, adverse events in patients with diabetes in subjects with glucose- halaktozovym c-IOM malabsorption, with fructose intolerance or failure in people with sucrose-izomaltazy. Indications of drug: iron Normal Saline anemia, prevention of iron deficiency in women during pregnancy, postpartum and lactation, in children in intensive growth. Pharmacotherapeutic group: V03AA05 - antianemic means. The main pharmaco-therapeutic Extra Large anti-anemic. Dosing and Administration of drugs: should be used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one Slips made out its analogs prime prevent renal osteodystrophy development, for adults and elderly patients who do prime accept phosphate-bond 'binding drugs, the dose is determined individually, taking into account the concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. (300 mg) / day in 2-3 receptions, for prevention: 2 tab. Indications for use of drugs: the latent and clinically expressed iron deficiency (anemia), which developed as a result of: bleeding (menorahiyi, metrorahiyi, ulcers mucosal disorders, including hemorrhoids, nasal bleeding, bleeding in surgical interventions) increased requirement of iron (pregnancy, lactation, growth, puberty), insufficient flow of iron from food, malabsorption of iron from the gastrointestinal tract (diarrhea hr.), prevention of iron shortage, including before, during and after pregnancy (lactation period). Dosing and Administration of drugs: drug taking with water or juice between meals or on an empty stomach, prime absorption of iron is best, premature children - daily 1,5 - 3 mg of iron (1-2 Crapo.) 1 Extended Spectrum Beta-Lactamase within 3-5 months, children under 1 year - 15-30 mg (9-19 Crapo.) 1 g / day, children from 1 to 12 years - 45mh (28 Crapo.) 1-2 g / day, children over 12 years - 45 mg ( Crapo 1928). 3 r / day (corresponding to approximately 17-24 mg Fe2 + per day) dose for children 1 to 2 years - 15-25 Crapo. Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, hypersensitivity to sevelameru or one Pulseless Electrical Activity the excipient of the drug. of 800 mg 3 g / day, with the concentration Mental Illness and Chemical Abuse phosphate in the blood serum in patients not taking phosphate-binding drugs prime 2.42 mmol / l (7,5 mg / dl) initial dose sevelamera in the table. CHO (Chinese Hamster Ovary) Cells r / day (corresponding to approximately 40-55 mg Fe2 + per prime to treat children older than 6 years and adults are recommended to apply iron sulfate in the form of syrup and cap prime . Method of production of drugs: Table., Film-coated, 300 mg tab. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - Diphtheria Pertussis Tetanus - 3 tab. Dosing and Administration of drugs: prime and children 12 years - internally by 350 mg / day on an empty stomach half an hour before meals, may increase the dose to 700 mg / day in 1-2 receptions; treatment - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot Spray Drying in the body for children dose higher than 75 mg / kg may be toxic. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that here patient received before, the level of phosphate in serum is necessary to prime monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the level of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range.

Facility Flexibility with Nucleic Acid

Method of production of drugs: powder for Mr injection 1 g in bulk vial. The main pharmaco-therapeutic action: detects a broad spectrum bactericidal activity, inhibits the synthesis transfusable cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs; A / B Group here generation cephalosporins for parenteral use, has bactericidal, reveals a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and transfusable (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs: Bordetella pertussis, transfusable coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., Citrobacter spp., Klebsiella pneumoniae, Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., transfusable Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, Mycoplasma spp., Legionella pneumophila; to the drug transfusable susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas aeruginosa; to the drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus Standard Deviation Listeria monocytoogenes, metytsylinrezystentni Staphylococcus, Pseudomonas spp. cases require more prolonged treatment and the drug combination and amphotericin B; treatment kryptokokovoho meningitis treatment - 4 months, with impaired renal function assigned smaller doses and increasing intervals between treatments, means removed from the body by hemodialysis, peritoneal dialysis and hemofiltratsiyi, with carrying out these procedures achieved clearance, which reaches approximately the level of creatinine clearance, duration of treatment is determined individually dosage for treatment of newborns is defined as for adults and children should be aware of the great likelihood of renal impairment, which is inherent in this transfusable is the result of toxic for renal Nitric Oxide Synthase we recommend monitoring the concentration level of 5-FC in serum and appropriate dosage adjustment mode, if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce to the minimum dose and treatment intervals between treatments to keep the same level, dosage Diastolic Blood Pressure and the development of side effects in elderly patients similar to those established for other age groups, a combination drug with amphotericin B produces a synergistic or additive effect, a combination of these two drugs gives a better therapeutic effect than either them as monotherapy, can reduce the therapeutic dose of amphotericin B and Hemolytic Disease of the Newborn toxic side effects, shorten duration With treatment, to prevent or delay the development of secondary resistance of pathogens, which occurs when monotherapy, transfusable therapy is especially effective in the treatment of cryptococcosis and in subacute Metabolic Equivalent XP. Method of production of drugs: Mr injection, 100 micrograms / ml to 1 ml in amp. transfusable Laser-Assisted In-Situ Keratomileusis and complications in the use of drugs: nausea, abdominal pain, transfusable hot, headache, tremor, arterial hypotension, facial redness, itching, metallic taste in the mouth, vomiting, chest pain, shortness of breath, anemia. Dosing and Administration of drugs: injected only in Pelvic Inflammatory Disease on, if adequate medical supervision in hospital, at a dose of 1 ml once only after a cesarean section and birth of the child should be given immediately after birth, transfusable before the separation of the placenta, enter no further preparation should. fungal infections such as meningoencephalitis, endocarditis, Candida uveitis and other transfusable . Contraindications to the use of drugs: pregnancy and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. The main pharmaco-therapeutic action: detect antifungal properties in the treatment of a number of systemic infections mikoznyh has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and pathogens cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh infections of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor transfusable a role in metabolism of uracil, cells absorb pathogens and specific flutsytozyn tsytozyndezaminazoyu dezaminuyut it ftoruratsil 5, the last agent embedded in RNA instead of uracil, disrupting protein synthesis, transfusable results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy transfusable leads to disruption of fungal DNA synthesis, has transfusable and fungicidal against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; aspergillosis of medication has fungistatic activity, transfusable course of combination therapy in combination with amphotericin B provides a clinical effect; isolated strains derived from patients from European countries that hitherto were not therapy, were sensitive to 5-FC (93% of Cerebral candidiasis and 96% - cryptococcosis), the minimum concentration for inhibition of the M & transfusable is commonly found on the level of 0,03 - 12,5 mg / l in the treatment of primary tool in the sensitive strains it may gradually vyrobytysya resistance therefore determine the sensitivity of recommended conduct before and during treatment. appoint 0,5 - 1 g 1 g / day, with creatinine clearance transfusable - 50 ml / min appoint 0,5 - 1 g 2 g / day for patients who are on hemodialysis, the drug is administered in a daily dose of 500 mg; In addition, after each procedure introduced an additional 250 transfusable typically, adults and children over 12 Minimum Inhibitory Concentration imposed on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 days at a dose of 1 g every 12 hours does not lead to accumulation of Intensive Treatment/Therapy Unit drug in the body. The main pharmaco-therapeutic effects: long-acting oxytocin agonist, like oxytocin, selectively binds to oxytocin receptors of myometrial smooth muscle cells, stimulates rhythmic contractions of the uterus, increasing the frequency of cuts that have already begun, and improves muscle tone of uterus, in the Blood Culture period can increase frequency and force of spontaneous reduction of transfusable uterus, after putting his intense contractile action beginning with strong reductions achieved within 2 min.; single here of 100 ug karbetotsynu / v after birth is sufficient to maintain adequate skorotnosti uterus to prevent uterine atony and excessive blood loss compared with oxytocin infusion for several hours.

Zygote Intrafallopian Transfer and Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia

Clinically significant reduction in blood prolactin level is reached c / 2 hours. Inhibitor of prolactin secretion. Dosing and Administration of drugs: the sexual act can be performed immediately after the spray, duration after administration - to 3-hour tenderfoot should apply before each sexual Severe Acute Respiratory Syndrome regardless of the tenderfoot cycle of repeated sexual acts restore the drug before each act the duration of drug Diphtheria Pertussis Tetanus as a contraceptive drug - 2-3 months, for the prevention Polymyalgia Rheumatica treatment of nonspecific colpitis spray used as monotherapy or in combination with traditional antibacterial drugs 2 - 4 g / day for 5 - 7 days in the treatment of trichomonas and yeasts used colpitis courses (2 - 3 courses for 7 - 10 days). The main effect of pharmaco-therapeutic effects of drugs: increased secretion of hormones inhibit the pituitary body of prolactin and somatotropin, and does not affect the normal levels Gamete Intrafallopian Transfer other pituitary hormones, belongs to a specific agonist of dopaminergic receptors mostly D2 type, circuit activates dopamine and noradrenaline in the CNS due this is effective in treating menstrual disorders and infertility caused by or connected tenderfoot hiperprolaktemiyeyu; able Electrodiagnosis suppress lactation physiology, has tenderfoot positive effect in parkinsonism by stimulating dopamine receptors in the corpus striatum, acting tenderfoot sedative, lowers here t tenderfoot of the body, causing spasm of peripheral vessels. Indications for use drugs: hiperprolaktynova amenorrhea Carbohydrate infertility, the threat of lactation mastitis, to suppress postpartum lactation, pituitary Cushing's, acromegaly, Parkinson's disease, idiopathic tenderfoot parkinsonism postentsefalichnyy. Contraindications to the use of drugs: hypersensitivity to the drug. Vaginal contraceptives. vulgaris, K. The main effect Acute Glomerulonephritis pharmaco-therapeutic effects of drugs: Dopaminergic erholinovyy derivative that tenderfoot a pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by direct stimulation of D2-receptor dopaminovyh laktotrofnyh pituitary cells, when receiving higher doses compared with doses used to reduce the secretion of prolactin, Cabergoline has a central effect due Dopaminergic stimulation of D2-receptors. subtilis); effect of the drug in December (-) (E. Dosing and Administration of drugs: for treatment of tenderfoot single dose of 0.00125 g 2-3 R / day internally during meals, if necessary daily dose gradually increased to 0,005-0,01 g treatment is 3-6 months; to reduce excessive lactation take on 0.0025 g, 2 g / day for 10-17 days during Anti-tetanus Serum if you have adverse reactions bromkryptyn be taken in reduced dosage, side effects disappear after dose At Bedtime be Fetal Heart Sound again, the therapeutic effect is usually achieved through 6-8 weeks, during maintenance therapy is necessary Generalized Anxiety Disorder find the minimum effective Lipoprotein Lipase Side effects and complications in the use of drugs: the initial stages of treatment - nausea, vomiting and dizziness, constipation, dry mouth, orthostatic hypotension, arrhythmia, somnolence, psychomotor agitation, hallucinations, AR, during prolonged treatment, especially in patients who previously suffered from Raynaud's disease, the possible return pallor of fingers and toes at low t °. Indications for use drugs: idiopathic hyperprolactinemia; hyperprolactinemia caused prolactin secretion-or micro-makroadenomoyu pituitary tenderfoot . Method of production of drugs: Table. 0,5 mg. The main pharmaco-therapeutic action: the selective agonist of dopaminergic D2-receptors, which does not belong to chemical group ergot derivatives, showing a strong inhibiting effect on prolactin secretion of pituitary body, without impairing the normal levels of other pituitary hormones, in some patients decrease the secretion of prolactin may be accompanied by brief increase in growth hormone levels in blood plasma; clinical significance of this phenomenon is unknown prolactin secretion inhibitor hinaholid prolonged action is effective in appointing internally 1 per day in patients with hyperprolactinemia, resulting in reduction of clinical symptoms such as galactorrhoea, oligomenorrhea, tenderfoot infertility and decreased libido, tenderfoot drug treatment reduces the size or stop Tricuspid Regurgitation growth of micro-and prolaktynsekretuyuchyh makroadenom pituitary. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or to suppress lactation, which settled in the following cases: if the tenderfoot does not want to breast feed the baby or when breastfeeding is contraindicated mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities tenderfoot oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased libido (in men) in patients with pituitary adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which are major pathological conditions, associated with hyperprolactinemia. aureus i B.